iX Biopharma Ltd

iX Biopharma Ltd

AGM Date Company Market Annual Report SIAS Questions Company Response
20161025 iX Biopharma Ltd Catalist Download 1. New drug application is extremely costly and time consuming and shareholders may not be... 2. For the benefit of the current shareholders, the group must manage its expenses and cash... 3. In the Remuneration section in the Corporate Governance report (page 19), the... Read More 1. Product: Wafermine™ Sublingual ketamine; PheoniX™ Sublingual... 2. Excluding share - based compensation, clinical t rials and... 3. RC commissioned Carrots Consulting to review the... Read More